Electrostimulation Suit in MS: Randomized Controlled Study
A clinical trial is planned with 100 participants to evaluate the effects of an electrostimulation suit on balance and walking in people with multiple sclerosis (MS), using standardized assessment scales. The study is randomized and controlled, comparing the treatment group to a sham-control group over 28 days of treatment.
- Tags
- #MSResearch
- Most relevant to
- —
- Source
- Read original source
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- No results yet
- Outcome
- Not reported
Why it matters
This research aims to determine whether the electrostimulation suit can induce clinically meaningful improvements in balance and walking for individuals with MS, which could influence future treatment approaches.
What this does not prove
No results have been reported yet, and planned enrollment and endpoints are not findings; therefore, current understanding of the intervention's effects is limited.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Interventional
- Participants / samples
- 100 · planned enrolment
- Randomised
- Yes
- Controlled
- Yes
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
Supporting passages (13)
study phasePhase: Not applicable
study designStudy type: Interventional
subjectsParticipants: people; ages from 18 Years to 70 Years; sex All
sample sizeEnrollment: 100 participants (estimated)
findingsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
limitationsTrial registry record. Publication date: unknown. No results are posted. Planned enrolment and endpoints are not findings.
peer reviewedTrial registry record.
randomizedAllocation: Randomized
controlledArm types: Experimental; Sham comparator
primary endpointPrimary endpoints: Balance responder rate: Percentage of patients achieving a clinically meaningful improvement in balance, as measured by the Berg Balance Scale (BBS), in the treatment group compared with sham-control group.; Walking responder rate: Percentage of patients achieving a clinically meaningful improvement in walking ability, on the transformed 0-100 Multiple Sclerosis Walking Scale-12 (MSWS-12), in the treatment group compared with the sham -control group.
interventionInterventions: Electrostimulation suit
follow upFollow-up: From Baseline 1 (start of treatment) to the post-treatment assessment after 28 days of treatment (-3/+10 days).
sample size basisEnrollment: 100 participants (estimated)
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.